Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"BES2T" (Bedside E-point Septal Separation Test) for Emergency Medicine Residents

NCT05506059 is registered in ClinicalTrials.gov with The Guthrie Clinic as lead sponsor.

NCT NCT05506059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05506059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"BES2T" (Bedside E-point Septal Separation Test) for Emergency Medicine Residents
Lead sponsor
The Guthrie Clinic
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2022
Completion date
August 11, 2023
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, stroke volume